Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Investigation of increased platelet alloimmunization screening in the era of pathogen-reduced platelets treated with psoralen/UV light.

Hendrickson JE, Mendoza H, Ross R, Siddon AJ, Gowda L, Hauser RG, Schulz WL, Tormey CA.

Transfusion. 2020 Mar;60(3):650-651. doi: 10.1111/trf.15691. No abstract available.

PMID:
32128834
2.

Passive anti-C acquired in the setting of Rh immune globulin administration following Rh mismatched apheresis platelet transfusion: A case series.

Sostin N, Ross R, Balbuena-Merle R, Hendrickson JE, Tormey CA.

J Clin Apher. 2020 Feb 28. doi: 10.1002/jca.21773. [Epub ahead of print]

PMID:
32110829
3.

The evanescence and persistence of RBC alloantibodies in blood donors.

Hauser RG, Esserman D, Karafin MS, Tan S, Balbuena-Merle R, Spencer BR, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Gottschall JL, Hendrickson JE, Tormey CA; (for the NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III)).

Transfusion. 2020 Feb 15. doi: 10.1111/trf.15718. [Epub ahead of print]

PMID:
32061102
4.

Cost savings to hospital of rituximab use in severe autoimmune acquired thrombotic thrombocytopenic purpura.

Goshua G, Gokhale A, Hendrickson JE, Tormey C, Lee AI.

Blood Adv. 2020 Feb 11;4(3):539-545. doi: 10.1182/bloodadvances.2019000827.

5.

Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal.

Thein SL, Pirenne F, Fasano RM, Habibi A, Bartolucci P, Chonat S, Hendrickson JE, Stowell SR.

Haematologica. 2020 Mar;105(3):539-544. doi: 10.3324/haematol.2019.224709. Epub 2020 Feb 6. No abstract available.

6.

American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, Kameka M, Kwiatkowski JL, Pirenne F, Shi PA, Stowell SR, Thein SL, Westhoff CM, Wong TE, Akl EA.

Blood Adv. 2020 Jan 28;4(2):327-355. doi: 10.1182/bloodadvances.2019001143.

7.

Application of PLASMIC score in prediction of ADAMTS13 deficiency in a pediatric case of acquired thrombotic thrombocytopenic purpura.

Gupta GK, Hendrickson JE, Tormey CA.

J Clin Apher. 2020 Jan 17. doi: 10.1002/jca.21767. [Epub ahead of print] No abstract available.

PMID:
31951292
8.

Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.

Nickel RS, Horan JT, Abraham A, Qayed M, Haight A, Ngwube A, Liang H, Luban NLC, Hendrickson JE.

Br J Haematol. 2019 Nov 1. doi: 10.1111/bjh.16298. [Epub ahead of print]

PMID:
31674662
9.

Fetal sex discordance between noninvasive prenatal screening results and sonography: A single institution's experience and review of the literature.

Sylvester-Armstrong KR, Rasmussen SA, Shoraka M, Hendrickson JE, Abu-Rustum RS.

Birth Defects Res. 2020 Mar 1;112(4):339-349. doi: 10.1002/bdr2.1594. Epub 2019 Sep 30. Review.

PMID:
31566914
10.

Mechanisms of alloimmunization in sickle cell disease.

Hudson KE, Fasano RM, Karafin MS, Hendrickson JE, Francis RO.

Curr Opin Hematol. 2019 Nov;26(6):434-441. doi: 10.1097/MOH.0000000000000540.

PMID:
31483335
11.

Type 1 IFN signaling critically regulates influenza-induced alloimmunization to transfused KEL RBCs in a murine model.

Liu D, Gibb DR, Escamilla-Rivera V, Liu J, Santhanakrishnan M, Shi Z, Xu L, Eisenbarth SC, Hendrickson JE.

Transfusion. 2019 Oct;59(10):3243-3252. doi: 10.1111/trf.15482. Epub 2019 Aug 12.

PMID:
31403208
12.

A murine neonatal model of necrotizing enterocolitis caused by anemia and red blood cell transfusions.

MohanKumar K, Namachivayam K, Song T, Jake Cha B, Slate A, Hendrickson JE, Pan H, Wickline SA, Oh JY, Patel RP, He L, Torres BA, Maheshwari A.

Nat Commun. 2019 Aug 2;10(1):3494. doi: 10.1038/s41467-019-11199-5.

13.

TRIX with treats: the considerable safety benefits of a transfusion medicine registry.

Hauser RG, Hendrickson JE, Tormey CA.

Transfusion. 2019 Aug;59(8):2489-2492. doi: 10.1111/trf.15449. No abstract available.

PMID:
31374148
14.

Red blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell disease.

Balbuena-Merle R, Curtis SA, Devine L, Gibb DR, Karafin MS, Luckey CJ, Tormey CA, Siddon AJ, Roberts JD, Hendrickson JE.

Transfusion. 2019 Oct;59(10):3219-3227. doi: 10.1111/trf.15463. Epub 2019 Jul 29.

PMID:
31355970
15.

Sepsis Attributed to Bacterial Contamination of Platelets Associated with a Potential Common Source - Multiple States, 2018.

Jones SA, Jones JM, Leung V, Nakashima AK, Oakeson KF, Smith AR, Hunter R, Kim JJ, Cumming M, McHale E, Young PP, Fridey JL, Kelley WE, Stramer SL, Wagner SJ, West FB, Herron R, Snyder E, Hendrickson JE, Peaper DR, Gundlapalli AV, Langelier C, Miller S, Nambiar A, Moayeri M, Kamm J, Moulton-Meissner H, Annambhotla P, Gable P, McAllister GA, Breaker E, Sula E, Halpin AL, Basavaraju SV.

MMWR Morb Mortal Wkly Rep. 2019 Jun 14;68(23):519-523. doi: 10.15585/mmwr.mm6823a2.

16.

Toll-like receptor SNPs and sickle cell disease: a PRRfect storm for RBC alloimmunization.

Hendrickson JE.

Br J Haematol. 2019 Sep;186(6):803-804. doi: 10.1111/bjh.16001. Epub 2019 Jun 2. No abstract available.

PMID:
31155710
17.

Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.

Balbuena-Merle R, West FB, Tormey CA, Hendrickson JE.

Transfusion. 2019 Jun;59(6):1911-1915. doi: 10.1111/trf.15240. Epub 2019 Mar 13.

PMID:
30865314
18.

Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.

Balbuena-Merle R, Hendrickson JE.

Transfus Clin Biol. 2019 May;26(2):112-115. doi: 10.1016/j.tracli.2019.02.003. Epub 2019 Feb 22. Review.

PMID:
30857806
19.

Microbial pathogen primary sequence inversely correlates with blood group antigen immunogenicity.

Baine I, Bahar B, Hendrickson JE, Hudson KE, Tormey CA.

Transfusion. 2019 May;59(5):1651-1656. doi: 10.1111/trf.15212. Epub 2019 Feb 27.

PMID:
30811034
20.

Transfusion-related red blood cell alloantibodies: induction and consequences.

Tormey CA, Hendrickson JE.

Blood. 2019 Apr 25;133(17):1821-1830. doi: 10.1182/blood-2018-08-833962. Epub 2019 Feb 26. Review.

PMID:
30808636
21.

Correction to: Autonomic dysfunction and HPV immunization: an overview.

Blitshteyn S, Brinth L, Hendrickson JE, Martinez-Lavin M.

Immunol Res. 2018 Dec;66(6):755. doi: 10.1007/s12026-018-9055-y.

PMID:
30574664
22.

Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion.

Patel SR, Gibb DR, Girard-Pierce K, Zhou X, Rodrigues LC, Arthur CM, Bennett AL, Jajosky RP, Fuller M, Maier CL, Zerra PE, Chonat S, Smith NH, Tormey CA, Hendrickson JE, Stowell SR.

Front Immunol. 2018 Nov 16;9:2516. doi: 10.3389/fimmu.2018.02516. eCollection 2018.

23.

Autonomic dysfunction and HPV immunization: an overview.

Blitshteyn S, Brinth L, Hendrickson JE, Martinez-Lavin M.

Immunol Res. 2018 Dec;66(6):744-754. doi: 10.1007/s12026-018-9036-1. Review. Erratum in: Immunol Res. 2018 Dec 21;:.

PMID:
30478703
24.

Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses.

Mener A, Patel SR, Arthur CM, Chonat S, Wieland A, Santhanakrishnan M, Liu J, Maier CL, Jajosky RP, Girard-Pierce K, Bennett A, Zerra PE, Smith NH, Hendrickson JE, Stowell SR.

JCI Insight. 2018 Nov 15;3(22). pii: 121631. doi: 10.1172/jci.insight.121631.

25.

Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Karafin MS, Tan S, Tormey CA, Spencer BR, Hauser RG, Norris PJ, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Gottschall JL, Hendrickson JE.

Transfusion. 2019 Jan;59(1):217-225. doi: 10.1111/trf.15004. Epub 2018 Nov 14.

PMID:
30427537
26.

Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model.

Madrid DJ, Santhanakrishnan M, Liu J, Gibb DR, Liu D, Natarajan P, Beitler D, Shi Z, Mo C, Tormey CA, Patel SR, Stowell SR, Hendrickson JE.

Blood Transfus. 2019 Sep;17(5):368-377. doi: 10.2450/2018.0178-18. Epub 2018 Nov 7.

27.

Antibody-mediated immune suppression by antigen modulation is antigen-specific.

Maier CL, Mener A, Patel SR, Jajosky RP, Bennett AL, Arthur CM, Hendrickson JE, Stowell SR.

Blood Adv. 2018 Nov 13;2(21):2986-3000. doi: 10.1182/bloodadvances.2018018408.

28.

Rhesus pieces: genotype matching of RBCs.

Hendrickson JE, Tormey CA.

Blood. 2018 Sep 13;132(11):1091-1093. doi: 10.1182/blood-2018-07-865634. No abstract available.

29.

Delayed haemolytic and serologic transfusion reactions: pathophysiology, treatment and prevention.

Siddon AJ, Kenney BC, Hendrickson JE, Tormey CA.

Curr Opin Hematol. 2018 Nov;25(6):459-467. doi: 10.1097/MOH.0000000000000462. Review.

PMID:
30124474
30.

Very low rate of anti-D development in male, primarily immunocompetent patients transfused with D-mismatched platelets.

Curtis G, Scott M, Orengo L, Hendrickson JE, Tormey CA.

Transfusion. 2018 Jun;58(6):1568-1569. doi: 10.1111/trf.14614. No abstract available.

PMID:
29949189
31.

Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen.

Mener A, Arthur CM, Patel SR, Liu J, Hendrickson JE, Stowell SR.

Front Immunol. 2018 Jun 11;9:676. doi: 10.3389/fimmu.2018.00676. eCollection 2018.

32.

Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.

Karafin MS, Westlake M, Hauser RG, Tormey CA, Norris PJ, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Hendrickson JE; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Br J Haematol. 2018 Jun;181(5):672-681. doi: 10.1111/bjh.15182. Epub 2018 Apr 19.

33.

Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey.

Stahl M, Pine A, Hendrickson JE, Litzow MR, Luger SM, Stone RM, Erba HP, Kim TK, Sekeres MA, Steensma DP, Komrokji RS, Gore SD, Zeidan AM.

Leuk Lymphoma. 2018 Nov;59(11):2723-2726. doi: 10.1080/10428194.2018.1452219. Epub 2018 Apr 18. No abstract available.

PMID:
29667455
34.

Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion.

Sullivan HC, Arthur CM, Thompson L, Patel SR, Stowell SR, Hendrickson JE, Lazarus AH.

Transfusion. 2018 Feb;58(2):542-544. doi: 10.1111/trf.14452. No abstract available.

PMID:
29411397
35.

Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory Overload.

Roubinian NH, Hendrickson JE, Triulzi DJ, Gottschall JL, Michalkiewicz M, Chowdhury D, Kor DJ, Looney MR, Matthay MA, Kleinman SH, Brambilla D, Murphy EL; National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Crit Care Med. 2018 Apr;46(4):577-585. doi: 10.1097/CCM.0000000000002948.

36.

A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia.

Curtis SA, Curtis BR, Lee AI, Hendrickson JE, Lacy J, Podoltsev NA.

Hematology. 2018 Aug;23(7):429-432. doi: 10.1080/10245332.2017.1419600. Epub 2017 Dec 28.

PMID:
29281948
37.

A multicentre study investigating vital sign changes occurring in complicated and uncomplicated transfusions.

Gehrie EA, Roubinian NH, Chowdhury D, Brambilla DJ, Murphy EL, Gottschall JL, Wu Y, Ness PM, Strauss RG, Hendrickson JE; NHLBI Recipient Epidemiology-Donor Evaluation Study (REDS-III).

Vox Sang. 2018 Feb;113(2):160-169. doi: 10.1111/vox.12621. Epub 2017 Dec 25.

38.

A novel association between high red blood cell alloimmunization rates and hereditary hemorrhagic telangiectasia.

Zheng Y, Pollak J, Henderson K, Hendrickson JE, Tormey CA.

Transfusion. 2018 Mar;58(3):775-780. doi: 10.1111/trf.14451. Epub 2017 Dec 6.

PMID:
29210083
39.

Innate B-1 B Cells Are Not Enriched in Red Blood Cell Autoimmune Mice: Importance of B Cell Receptor Transgenic Selection.

Richards AL, Howie HL, Kapp LM, Hendrickson JE, Zimring JC, Hudson KE.

Front Immunol. 2017 Nov 3;8:1366. doi: 10.3389/fimmu.2017.01366. eCollection 2017.

40.

Autoimmunity, Autonomic Neuropathy, and the HPV Vaccination: A Vulnerable Subpopulation.

Schofield JR, Hendrickson JE.

Clin Pediatr (Phila). 2018 May;57(5):603-606. doi: 10.1177/0009922817728701. Epub 2017 Sep 4. No abstract available.

PMID:
28868890
41.

Preanalytical errors in transfusion medicine: Reply to "74-year-old female with new monoclonal protein on serum immunofixation electrophoresis".

Cheng C, Gokhale A, Tormey CA, Hendrickson JE, Bahar B.

Clin Biochem. 2017 Dec;50(18):1334-1335. doi: 10.1016/j.clinbiochem.2017.08.018. Epub 2017 Aug 31. No abstract available.

PMID:
28864294
42.

B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice.

Gibb DR, Liu J, Santhanakrishnan M, Natarajan P, Madrid DJ, Patel S, Eisenbarth SC, Tormey CA, Stowell SR, Iwasaki A, Hendrickson JE.

Transfusion. 2017 Nov;57(11):2595-2608. doi: 10.1111/trf.14288. Epub 2017 Aug 23.

43.

CD4 Depletion or CD40L Blockade Results in Antigen-Specific Tolerance in a Red Blood Cell Alloimmunization Model.

Natarajan P, Liu D, Patel SR, Santhanakrishnan M, Beitler D, Liu J, Gibb DR, Liepkalns JS, Madrid DJ, Eisenbarth SC, Stowell SR, Hendrickson JE.

Front Immunol. 2017 Aug 7;8:907. doi: 10.3389/fimmu.2017.00907. eCollection 2017.

44.

Therapeutic Plasma Exchange and Its Impact on Drug Levels: An ACLPS Critical Review.

Cheng CW, Hendrickson JE, Tormey CA, Sidhu D.

Am J Clin Pathol. 2017 Sep 1;148(3):190-198. doi: 10.1093/ajcp/aqx056. Review.

PMID:
28821193
45.

Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.

Gibb DR, Liu J, Natarajan P, Santhanakrishnan M, Madrid DJ, Eisenbarth SC, Zimring JC, Iwasaki A, Hendrickson JE.

J Immunol. 2017 Aug 1;199(3):1041-1050. doi: 10.4049/jimmunol.1700401. Epub 2017 Jun 19.

46.

The impact of vaccination on RBC alloimmunization in a murine model.

Natarajan P, Santhanakrishnan M, Tormey CA, Hendrickson JE.

Vox Sang. 2017 Aug;112(6):598-600. doi: 10.1111/vox.12541. Epub 2017 Jun 8.

47.

Irradiation of Red Blood Cells and Alloimmunization.

Tormey CA, Hendrickson JE.

Lab Med. 2017 May 1;48(2):172-177. doi: 10.1093/labmed/lmx018.

PMID:
28340248
48.

A novel network analysis tool to identify relationships between disease states and risks for red blood cell alloimmunization.

Celli R, Schulz W, Hendrickson JE, Tormey CA.

Vox Sang. 2017 Jul;112(5):469-472. doi: 10.1111/vox.12515. Epub 2017 Mar 23.

PMID:
28337751
49.

Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion.

Arthur CM, Patel SR, Smith NH, Bennett A, Kamili NA, Mener A, Gerner-Smidt C, Sullivan HC, Hale JS, Wieland A, Youngblood B, Zimring JC, Hendrickson JE, Stowell SR.

J Immunol. 2017 Apr 1;198(7):2671-2680. doi: 10.4049/jimmunol.1601736. Epub 2017 Mar 1.

50.

Limitations of a scoring model to predict thrombotic thrombocytopaenic purpura.

Cheng C, Tormey CA, Hendrickson JE.

Vox Sang. 2017 Feb;112(2):185-186. doi: 10.1111/vox.12480. Epub 2017 Jan 18. No abstract available.

PMID:
28098338

Supplemental Content

Loading ...
Support Center